Lantheus Holdings, Inc.

Lantheus Holdings, Inc.verified

LNTH

Price:

$63.645

Market Cap:

$4.36B

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors. The company also of...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2015-06-25

Stock Exchange

NASDAQ

Ticker

LNTH

The PE Ratio as of April 2024 (TTM) for Lantheus Holdings, Inc. (LNTH) is 13.69

According to Lantheus Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 13.69. This represents a change of -111.81% compared to the average of -115.91 of the last 4 quarters.

Lantheus Holdings, Inc. (LNTH) Historical PE Ratio (quarterly & annually)

How has LNTH PE Ratio performed in the past?

The mean historical PE Ratio of Lantheus Holdings, Inc. over the last ten years is 7.28. The current 13.69 PE Ratio has changed 18.71% with respect to the historical average. Over the past ten years (40 quarters), LNTH's PE Ratio was at its highest in in the December 2014 quarter at 197.00. The PE Ratio was at its lowest in in the March 2023 quarter at -498.16.

Quarterly (TTM)
Annual

Average

7.28

Median

8.24

Minimum

-54.20

Maximum

124.35

Lantheus Holdings, Inc. (LNTH) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Lantheus Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.60%

Maximum Annual PE Ratio = 124.35

Minimum Annual Increase = -554.61%

Minimum Annual PE Ratio = -54.20

Quarterly (TTM)
Annual
YearPE RatioChange
202312.96-89.58%
2022124.35-554.61%
2021-27.35-49.54%
2020-54.20-314.65%
201925.2571.00%
201814.77139.03%
20176.18-40.00%
201610.30-283.82%
2015-5.60-83.45%
2014-33.851.60%

Lantheus Holdings, Inc. (LNTH) Average PE Ratio

How has LNTH PE Ratio performed in the past?

The current PE Ratio of Lantheus Holdings, Inc. (LNTH) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

36.65

5-year avg

16.20

10-year avg

7.28

Lantheus Holdings, Inc. (LNTH) PE Ratio vs. Peers

How is LNTH’s PE Ratio compared to its peers?

Lantheus Holdings, Inc.’s PE Ratio is less than Neurocrine Biosciences, Inc. (55.54), greater than Deciphera Pharmaceuticals, Inc. (-6.72), greater than Ironwood Pharmaceuticals, Inc. (-1.29), greater than Alkermes plc (11.62), greater than Avadel Pharmaceuticals plc (-10.58), less than ANI Pharmaceuticals, Inc. (0), less than Dr. Reddy's Laboratories Limited (66.97), less than Collegium Pharmaceutical, Inc. (18.99), less than Pacira BioSciences, Inc. (24.00), less than Alvotech (29.44), greater than Catalent, Inc. (-6.48), greater than Amphastar Pharmaceuticals, Inc. (-8.25), less than Journey Medical Corporation (14.18), greater than Aquestive Therapeutics, Inc. (-18.02), less than Dynavax Technologies Corporation (89.94), greater than null (-243.92),

Build a custom stock screener for Lantheus Holdings, Inc. (LNTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lantheus Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lantheus Holdings, Inc. (LNTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lantheus Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Lantheus Holdings, Inc.'s PE Ratio?

How is the PE Ratio calculated for Lantheus Holdings, Inc. (LNTH)?

What is the highest PE Ratio for Lantheus Holdings, Inc. (LNTH)?

What is the 3-year average PE Ratio for Lantheus Holdings, Inc. (LNTH)?

What is the 5-year average PE Ratio for Lantheus Holdings, Inc. (LNTH)?

How does the current PE Ratio for Lantheus Holdings, Inc. (LNTH) compare to its historical average?